TRIZIVIR

Product NDC

49702-217

11-digit product format

497020217

Labeler code

49702

Product ID

49702-217_1001c7d9-56da-44f8-ba9c-a45be7a239b7

Type

HUMAN PRESCRIPTION DRUG

Nonproprietary name

abacavir sulfate, lamivudine, and zidovudine

Dosage form

TABLET, FILM COATED

Route

ORAL

Labeler

ViiV Healthcare Company

Application

NDA021205

Marketing category

NDA

Marketing start

2010-11-02

Marketing end

0000-00-00

Substance

ABACAVIR SULFATE; LAMIVUDINE; ZIDOVUDINE

Active strength

300 mg/1; mg/1; mg/1

Pharmacologic classes

Cytochrome P450 1A1 Inhibitors [MoA], Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleoside Reverse Transcriptase Inhibitors [MoA]

NDC exclude flag

No

Listing certified through

2023-12-31

Current FDA listing

Historical FDA.report record